Celldex Therapeutics, Inc. (CLDX): EBITDA
-$283.99M
Year ended 2025-12-31
-$322.43M
Trailing 12 months to 2026-06-30
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$283.99M | n/m | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | -$191.90M | n/m | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | -$151.53M | n/m | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | -$112.34M | n/m | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | -$68.17M | n/m | 2024-02-26, From 2021-01-01 |
| 2020-12-31 | -$59.42M | n/m | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | -$50.17M | n/m | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | -$152.86M | n/m | 2021-03-29, From 2018-01-01 |
| 2017-12-31 | -$117.11M | n/m | 2020-03-26, From 2017-01-01 |
| 2016-12-31 | -$129.82M | n/m | 2019-03-07, From 2016-01-01 |
| 2015-12-31 | -$126.54M | n/m | 2018-03-07, From 2015-01-01 |
| 2014-12-31 | -$120.04M | n/m | 2017-03-14, From 2014-01-01 |
| 2013-12-31 | -$79.51M | n/m | 2016-02-25, From 2013-01-01 |
| 2012-12-31 | -$56.03M | n/m | 2015-02-24, From 2012-01-01 |
| 2011-12-31 | -$41.15M | n/m | 2014-03-03, From 2011-01-01 |
| 2010-12-31 | -$3.74M | n/m | 2013-03-08, From 2010-01-01 |
| 2009-12-31 | -$34.27M | n/a | 2012-03-08, From 2009-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | 2025-12-31 | -$283.99M | n/m |
| Volitionrx Ltd (VNRX) | 2025-12-31 | -$20.75M | n/m |
| Insight Molecular Diagnostics Inc. (IMDX) | 2025-12-31 | -$48.93M | n/m |
| Biomerica Inc (BMRA) | 2026-05-31 | -$5.24M | n/m |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | -$7.80M | n/m |
| Immucell Corp (ICCC) | 2025-12-31 | $4.43M | +306.8% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | -$10.63M | n/m |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | -$431.22M | n/m |
| Cardio Diagnostics Holdings, Inc. (CDIO) | 2025-12-31 | -$6.42M | n/m |
Compare CLDX, VNRX, IMDX, BMRA side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗